A patient came to Color with a pancreatic cancer diagnosis from their treating provider. After reviewing the case through our tumor board, our clinicians identified the diagnosis as incorrect. It was actually cholangiocarcinoma, or bile duct cancer, a different disease requiring a completely different treatment plan, prognosis, and clinical trial options.
Because a partnership had been built with the treating provider from day one, Color caught the error before therapy began, avoided unnecessary treatment, and moved the patient quickly into the right care.